GB1381872A - Pharmaceutical compositions for inhalation - Google Patents
Pharmaceutical compositions for inhalationInfo
- Publication number
- GB1381872A GB1381872A GB2920771A GB2920771A GB1381872A GB 1381872 A GB1381872 A GB 1381872A GB 2920771 A GB2920771 A GB 2920771A GB 2920771 A GB2920771 A GB 2920771A GB 1381872 A GB1381872 A GB 1381872A
- Authority
- GB
- United Kingdom
- Prior art keywords
- inhalation
- june
- microns
- particle size
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 abstract 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 abstract 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 abstract 1
- -1 4-oxo-4H-1-benzopyran-2-yl Chemical group 0.000 abstract 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 1
- 101100234822 Caenorhabditis elegans ltd-1 gene Proteins 0.000 abstract 1
- 241000790917 Dioxys <bee> Species 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 abstract 1
- ROSXARVHJNYYDO-UHFFFAOYSA-N Propyliodone Chemical compound CCCOC(=O)CN1C=C(I)C(=O)C(I)=C1 ROSXARVHJNYYDO-UHFFFAOYSA-N 0.000 abstract 1
- 235000021355 Stearic acid Nutrition 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 229960004308 acetylcysteine Drugs 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 229960000265 cromoglicic acid Drugs 0.000 abstract 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 1
- VLARUOGDXDTHEH-UHFFFAOYSA-L disodium cromoglycate Chemical compound [Na+].[Na+].O1C(C([O-])=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C([O-])=O)O2 VLARUOGDXDTHEH-UHFFFAOYSA-L 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 abstract 1
- 229960002179 ephedrine Drugs 0.000 abstract 1
- 229960001317 isoprenaline Drugs 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 abstract 1
- 229960005489 paracetamol Drugs 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 229960003927 propyliodone Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000008117 stearic acid Substances 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
- 229910052715 tantalum Inorganic materials 0.000 abstract 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 229930101283 tetracycline Natural products 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
- 150000003536 tetrazoles Chemical class 0.000 abstract 1
- 229960000278 theophylline Drugs 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Otolaryngology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2920771A GB1381872A (en) | 1971-06-22 | 1971-06-22 | Pharmaceutical compositions for inhalation |
| ZA723999A ZA723999B (en) | 1971-06-22 | 1972-06-12 | Pharmaceutical powder composition suitable for inhalation |
| CA144,512A CA970685A (en) | 1971-06-22 | 1972-06-13 | Composition containing inhalation medicaments |
| NLAANVRAGE7208207,A NL176743C (nl) | 1971-06-22 | 1972-06-15 | Verbetering van de werkwijze volgens octrooischrift 161.984 ter bereiding van een farmaceutisch poedervormig inhaleerpreparaat, alsmede een houder, die een dergelijk preparaat bevat. |
| DE2229981A DE2229981C3 (de) | 1971-06-22 | 1972-06-20 | Pharmazeutische Pulverpräparate |
| FR7222310A FR2143163B2 (enrdf_load_stackoverflow) | 1971-06-22 | 1972-06-21 | |
| DK309072AA DK134970B (da) | 1971-06-22 | 1972-06-21 | Fremgangsmåde til fremstilling af et til inhalering beregnet farmaceutisk middel i pulverform. |
| AU43805/72A AU462722B2 (en) | 1971-06-22 | 1972-06-22 | Pharmaceutical powder composition for inhalation |
| JP48050403A JPS5046820A (enrdf_load_stackoverflow) | 1971-06-22 | 1973-05-08 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2920771A GB1381872A (en) | 1971-06-22 | 1971-06-22 | Pharmaceutical compositions for inhalation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1381872A true GB1381872A (en) | 1975-01-29 |
Family
ID=10287853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2920771A Expired GB1381872A (en) | 1971-06-22 | 1971-06-22 | Pharmaceutical compositions for inhalation |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS5046820A (enrdf_load_stackoverflow) |
| AU (1) | AU462722B2 (enrdf_load_stackoverflow) |
| CA (1) | CA970685A (enrdf_load_stackoverflow) |
| DE (1) | DE2229981C3 (enrdf_load_stackoverflow) |
| DK (1) | DK134970B (enrdf_load_stackoverflow) |
| FR (1) | FR2143163B2 (enrdf_load_stackoverflow) |
| GB (1) | GB1381872A (enrdf_load_stackoverflow) |
| NL (1) | NL176743C (enrdf_load_stackoverflow) |
| ZA (1) | ZA723999B (enrdf_load_stackoverflow) |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2512670A1 (fr) * | 1981-06-04 | 1983-03-18 | Lofarma Farma Lab | Capsules contenant le principe actif d'un allergene et procede pour leur preparation |
| US4515805A (en) * | 1980-11-05 | 1985-05-07 | Fisons Plc | Soluble sodium cromoglycate compositions |
| US6153224A (en) * | 1995-01-31 | 2000-11-28 | Co-Ordinated Drug Development Limited | Carrier particles for use in dry powder inhalers |
| US6183782B1 (en) | 1994-03-15 | 2001-02-06 | Glaxo Group Limited | Inhalation composition containing lactose pellets |
| WO2001026630A1 (fr) * | 1999-10-12 | 2001-04-19 | Kaken Pharmaceutical Co., Ltd. | Preparations pour inhalation en poudre et leur procede de production |
| US6221338B1 (en) | 1993-10-26 | 2001-04-24 | Vectura Limited | Method of producing particles for use in dry powder inhalers |
| US6284287B1 (en) | 1994-07-16 | 2001-09-04 | Asta Medica Ag | Particulate formulation for administration by inhalation |
| US6475523B1 (en) | 1995-07-24 | 2002-11-05 | Vectura Limited | Powders comprising anti-adherant materials for use in dry powder inhalers |
| US6884794B2 (en) | 2000-04-17 | 2005-04-26 | Chiesi Farmaceutici S.P.A. | Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| WO2005046586A2 (en) | 2003-11-04 | 2005-05-26 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
| WO2005104745A2 (en) | 2004-04-27 | 2005-11-10 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
| US7399528B2 (en) | 1999-07-16 | 2008-07-15 | Chiesi Farmaceutici S.P.A. | Powder particles with smooth surface for use in inhalation therapy |
| US7541022B2 (en) | 2000-04-17 | 2009-06-02 | Vectura Limited | Pharmaceutical formulations for dry powder inhalers |
| EP2283817B1 (en) | 2000-11-30 | 2016-05-18 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| US9365905B2 (en) | 2005-02-10 | 2016-06-14 | Dmv-Fonterra Excipients Technology Gmbh | Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom |
| US10238601B2 (en) | 2000-11-30 | 2019-03-26 | Vectura Limited | Particles for use in a pharmaceutical composition |
| EP2266549B1 (en) | 2000-06-27 | 2019-08-07 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| WO2020031119A1 (en) | 2018-08-07 | 2020-02-13 | Norton (Waterford) Limited | Application of raman spectroscopy for the manufacture of inhalation powders |
| US11090294B2 (en) | 2009-12-01 | 2021-08-17 | Glaxo Group Limited | Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist |
| US11116721B2 (en) | 2009-02-26 | 2021-09-14 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol |
| EP4316473A2 (en) | 2013-03-28 | 2024-02-07 | Vectura Limited | Use of stearate in an inhalable formulation |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2332663C2 (de) * | 1973-06-23 | 1986-07-31 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie |
| GB1520247A (en) * | 1974-08-10 | 1978-08-02 | Fisons Ltd | Pelletised medicament formulations |
| GB1571629A (en) * | 1977-11-30 | 1980-07-16 | Fisons Ltd | Pharmaceutical compositions containing beclomethasone dipropionate |
| JPS6034925B2 (ja) * | 1979-07-31 | 1985-08-12 | 帝人株式会社 | 持続性鼻腔用製剤およびその製造法 |
| JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
| DE3688617T2 (de) * | 1986-11-03 | 1993-11-18 | Allen W Jacobs | Verfahren zur Beimischung einer festen teilchenförmigen Komponente in Aerosolpräparate zur Inhalation des Nikotins. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1122284A (en) * | 1965-03-19 | 1968-08-07 | Fisons Pharmaceuticals Ltd | Inhalation device |
| GB1242211A (en) * | 1967-08-08 | 1971-08-11 | Fisons Pharmaceuticals Ltd | Pharmaceutical composition |
-
1971
- 1971-06-22 GB GB2920771A patent/GB1381872A/en not_active Expired
-
1972
- 1972-06-12 ZA ZA723999A patent/ZA723999B/xx unknown
- 1972-06-13 CA CA144,512A patent/CA970685A/en not_active Expired
- 1972-06-15 NL NLAANVRAGE7208207,A patent/NL176743C/xx active Search and Examination
- 1972-06-20 DE DE2229981A patent/DE2229981C3/de not_active Expired
- 1972-06-21 FR FR7222310A patent/FR2143163B2/fr not_active Expired
- 1972-06-21 DK DK309072AA patent/DK134970B/da not_active IP Right Cessation
- 1972-06-22 AU AU43805/72A patent/AU462722B2/en not_active Expired
-
1973
- 1973-05-08 JP JP48050403A patent/JPS5046820A/ja active Pending
Cited By (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4515805A (en) * | 1980-11-05 | 1985-05-07 | Fisons Plc | Soluble sodium cromoglycate compositions |
| EP0067130A3 (en) * | 1981-06-04 | 1984-01-11 | Lofarma Farma Lab | Capsules containing the active principle of an allergen, and process for their preparation |
| FR2512670A1 (fr) * | 1981-06-04 | 1983-03-18 | Lofarma Farma Lab | Capsules contenant le principe actif d'un allergene et procede pour leur preparation |
| US6221338B1 (en) | 1993-10-26 | 2001-04-24 | Vectura Limited | Method of producing particles for use in dry powder inhalers |
| US8137657B2 (en) | 1993-10-26 | 2012-03-20 | Vectura Limited | Carrier particles for use in dry powder inhalers |
| US6582678B2 (en) | 1993-10-26 | 2003-06-24 | Vectura Limited | Carrier particles for use in dry powder inhalers |
| US6955824B1 (en) | 1994-03-15 | 2005-10-18 | Glaxo Group Limited | Inhalation composition containing lactose pellets |
| US6183782B1 (en) | 1994-03-15 | 2001-02-06 | Glaxo Group Limited | Inhalation composition containing lactose pellets |
| US6284287B1 (en) | 1994-07-16 | 2001-09-04 | Asta Medica Ag | Particulate formulation for administration by inhalation |
| US8920781B2 (en) | 1995-01-31 | 2014-12-30 | Vectura Limited | Carrier particles for use in dry powder inhalers |
| US6153224A (en) * | 1995-01-31 | 2000-11-28 | Co-Ordinated Drug Development Limited | Carrier particles for use in dry powder inhalers |
| US7011818B2 (en) | 1995-01-31 | 2006-03-14 | Vectura Limited | Carrier particles for use in dry powder inhalers |
| US7718163B2 (en) | 1995-01-31 | 2010-05-18 | Vectura Limited (01696917) | Carrier particles for use in dry powder inhalers |
| US6475523B1 (en) | 1995-07-24 | 2002-11-05 | Vectura Limited | Powders comprising anti-adherant materials for use in dry powder inhalers |
| US7399528B2 (en) | 1999-07-16 | 2008-07-15 | Chiesi Farmaceutici S.P.A. | Powder particles with smooth surface for use in inhalation therapy |
| WO2001026630A1 (fr) * | 1999-10-12 | 2001-04-19 | Kaken Pharmaceutical Co., Ltd. | Preparations pour inhalation en poudre et leur procede de production |
| US7022311B1 (en) | 1999-10-12 | 2006-04-04 | Kaken Pharmaceutical Co., Ltd. | Powdery inhalational preparations and process for producing the same |
| US6884794B2 (en) | 2000-04-17 | 2005-04-26 | Chiesi Farmaceutici S.P.A. | Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| US9566239B2 (en) | 2000-04-17 | 2017-02-14 | Vectura Limited | Pharmaceutical formulations for dry powder inhalers |
| US7541022B2 (en) | 2000-04-17 | 2009-06-02 | Vectura Limited | Pharmaceutical formulations for dry powder inhalers |
| EP1719505A2 (en) | 2000-04-17 | 2006-11-08 | CHIESI FARMACEUTICI S.p.A. | Pharmaceutical formulations for dry powder inhalers in the form of hard pellets |
| EP2272508A2 (en) | 2000-04-17 | 2011-01-12 | Vectura Limited | Pharmaceutical Formulations for Dry Powder Inhalers |
| US7223748B2 (en) | 2000-04-17 | 2007-05-29 | Chiesi Farmaceutici S.P.A. | Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| US8871274B2 (en) | 2000-04-17 | 2014-10-28 | Vectura Limited | Pharmaceutical formulations for dry powder inhalers |
| EP2266549B1 (en) | 2000-06-27 | 2019-08-07 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| US9962338B2 (en) | 2000-11-30 | 2018-05-08 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| US10449161B2 (en) | 2000-11-30 | 2019-10-22 | Vectura Limited | Pharmaceutical compositions for inhalation |
| US10973771B2 (en) | 2000-11-30 | 2021-04-13 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| US9931304B2 (en) | 2000-11-30 | 2018-04-03 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| EP2283817B1 (en) | 2000-11-30 | 2016-05-18 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| US10188612B2 (en) | 2000-11-30 | 2019-01-29 | Vectura Limited | Pharmaceutical compositions for inhalation |
| US10238601B2 (en) | 2000-11-30 | 2019-03-26 | Vectura Limited | Particles for use in a pharmaceutical composition |
| WO2005046586A2 (en) | 2003-11-04 | 2005-05-26 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
| EP2570128A1 (en) | 2004-04-27 | 2013-03-20 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
| WO2005104745A2 (en) | 2004-04-27 | 2005-11-10 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
| US9365905B2 (en) | 2005-02-10 | 2016-06-14 | Dmv-Fonterra Excipients Technology Gmbh | Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom |
| US11116721B2 (en) | 2009-02-26 | 2021-09-14 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol |
| US11090294B2 (en) | 2009-12-01 | 2021-08-17 | Glaxo Group Limited | Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist |
| US12396986B2 (en) | 2009-12-01 | 2025-08-26 | Glaxo Group Limited | Combinations of a muscarinic receptor antagonist and a β-2 adrenoreceptor agonist |
| EP4316473A2 (en) | 2013-03-28 | 2024-02-07 | Vectura Limited | Use of stearate in an inhalable formulation |
| EP4360626A2 (en) | 2013-03-28 | 2024-05-01 | Vectura Limited | Use of stearate in an inhalable formulation |
| WO2020031119A1 (en) | 2018-08-07 | 2020-02-13 | Norton (Waterford) Limited | Application of raman spectroscopy for the manufacture of inhalation powders |
| EP3910324A1 (en) | 2018-08-07 | 2021-11-17 | Norton (Waterford) Limited | Application of raman spectroscopy for the manufacture of inhalation powders |
Also Published As
| Publication number | Publication date |
|---|---|
| NL176743B (nl) | 1985-01-02 |
| DK134970B (da) | 1977-02-21 |
| DE2229981C3 (de) | 1981-04-02 |
| NL176743C (nl) | 1985-06-03 |
| NL7208207A (enrdf_load_stackoverflow) | 1972-12-28 |
| CA970685A (en) | 1975-07-08 |
| DE2229981B2 (de) | 1980-07-03 |
| DE2229981A1 (de) | 1972-12-28 |
| AU4380572A (en) | 1974-01-03 |
| FR2143163B2 (enrdf_load_stackoverflow) | 1975-10-31 |
| ZA723999B (en) | 1973-06-27 |
| FR2143163A2 (enrdf_load_stackoverflow) | 1973-02-02 |
| DK134970C (enrdf_load_stackoverflow) | 1977-07-18 |
| JPS5046820A (enrdf_load_stackoverflow) | 1975-04-25 |
| AU462722B2 (en) | 1975-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1381872A (en) | Pharmaceutical compositions for inhalation | |
| GB1242211A (en) | Pharmaceutical composition | |
| DK0706383T3 (da) | Praeparat til inhalation | |
| DK0663815T3 (da) | Inhalationspulvere og fremgangsmåde til fremstilling heraf | |
| DE3363321D1 (en) | Long-lasting three layered pharmaceutical film preparations | |
| PT843558E (pt) | Composicao para uma melhor absorcao de drogas polares a partir do colon | |
| KR970704422A (ko) | 투여용 약제학적 조성물 | |
| IL77186A0 (en) | Pharmaceutical insulin composition | |
| GB1520247A (en) | Pelletised medicament formulations | |
| DE3680866D1 (de) | Herstellungsverfahren fuer arzneimittel mit verzoegerter wirkstoffabgabe. | |
| ES2090712T3 (es) | Medicamento agudo que contiene ibuprofeno y su uso. | |
| ATE104146T1 (de) | Zubereitung mit verzoegerter freigabe eines hydrochlorids eines basischen arzneistoffs. | |
| IL47937A (en) | Pharmaceutical compositions containing 6,8-diethyl-5-hydroxy-4-oxo-4h-1-benzopyran-2-carboxylic acid or a salt thereof | |
| GB934089A (en) | Improvements in or relating to sustained release medicaments | |
| ES2171459T3 (es) | Polvo para administracion nasal de farmaco peptidico o proteinaceo. | |
| GB1423985A (en) | Pharmaceutical compositions containing bischromonyloxy compounds | |
| FR2287216A1 (fr) | Nouvelle forme galenique d'administration de medicaments et medicaments prepares sous cette nouvelle forme | |
| GB1442159A (en) | Pharmaceutical compositions containing paracetamol | |
| GB1302266A (enrdf_load_stackoverflow) | ||
| GB1356965A (en) | Pharmaceutical composition | |
| IL39889A0 (en) | Inhalant compositions containing an anticholinergically active compound,and inhalers for the administration thereof | |
| US2676902A (en) | Para-aminosalicylic acid containing compositions | |
| GB1235529A (en) | Composition for mucolysis | |
| RU94040242A (ru) | Способ лечения туберкулеза | |
| GB1446237A (en) | Pharmaceutical preparations containing pyrazolones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |